TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members

Citations Over TimeTop 13% of 2022 papers

Abstract

We overcame ethical and logistic challenges to demonstrate that retrospective genetic testing to identify PVs in previously untested deceased probands with TOC is feasible. Understanding reasons for a family member's decision to accept or decline a referral will be important for guiding future TRACEBACK projects.

Related Papers

• → Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic Testing(2016)24 cited
• → Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes(2021)6 cited
• → Risk of major congenital malformations in the offsprings of women with epilepsy is not related to family history(2008)9 cited
• → Retrospective Analysis of Familial Clustering for Malignant Melanoma(2004)
• [Prenatal genetic counseling and instruction for deaf families by genetic test].(2011)